Bifidobacterium pseudocatenulatum alleviates neonatal calf diarrhea via acetate-associated attenuation of pathogen-induced Th17/IL-17A inflammatory responses

Abstract Background Neonatal calf diarrhea is a major challenge in livestock production and is often driven by pathogen-induced intestinal inflammation and gut dysbiosis. While the therapeutic potential of Bifidobacterium ( B. ) pseudocatenulatum is recognized, its mechanistic interplay with diarrhea-associated inflammatory pathology in calves remains poorly defined. This study investigated how B. pseudocatenulatum alleviates calf diarrhea and intestinal inflammation, with a focus on acetate metabolism and the T helper 17 (Th17)/IL-17A immune axis. Results Diarrheic calves exhibited pronounced gut microbial dysbiosis, metabolic perturbation, and inflammatory activation. Fecal microbiota transplantation (FMT) from healthy calves alleviated diarrhea and was accompanied by enrichment of B. pseudocatenulatum and increased fecal acetate. In vitro, live B. pseudocatenulatum increased acetate production. In complementary murine inflammatory models, B. p seudocatenulatum and acetate alleviated intestinal injury and inflammatory phenotypes. The protective effect was attenuated in the heat-killed B. pseudocatenulatum -treated group. Mechanistically, these protective effects were accompanied by attenuation of pathogen-induced Th17/IL-17A-related responses rather than broad suppression of basal Th17 activation. Pharmacological blockade of free fatty acid receptor 2 (FFAR2) attenuated the protective effect of live B. pseudocatenulatum , supporting the involvement of acetate-associated receptor signaling. Conclusion This study revealed B. pseudocatenulatum as a microbiota-associated candidate linked to calf diarrhea remission and supports acetate-associated attenuation of pathogen-induced Th17/IL-17A-related inflammatory responses as one component of its protective effect. These findings establish a microbiota–metabolite–immune regulatory framework, providing novel therapeutic strategies for alleviating intestinal inflammation and calf diarrhea.

Authors

Institutions

Publication Details

Journal
Microbiome
Published
2026-09-01
DOI
https://doi.org/10.1186/s40168-026-02524-4
Primary Topic
Animal health and immunology
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Bifidobacterium pseudocatenulatum alleviates neonatal calf diarrhea via acetate-associated attenuation of pathogen-induced Th17/IL-17A inflammatory responses

Qingbiao Xu, Linhai Yang, W. Si, Jinxiu Hou et al.
Microbiome
Animal health and immunology
article

Bifidobacterium pseudocatenulatum alleviates neonatal calf diarrhea via acetate-associated attenuation of pathogen-induced Th17/IL-17A inflammatory responses

Qingbiao Xu, Linhai Yang, W. Si, Jinxiu Hou, Huizeng Sun, Leluo Guan, Zhongtang Yu, Mingyang Hu, Wenjuan Du, Hongyun Liu, Ya Gao, Wenyue Li, Yufeng Du
article en

Abstract

Abstract Background Neonatal calf diarrhea is a major challenge in livestock production and is often driven by pathogen-induced intestinal inflammation and gut dysbiosis. While the therapeutic potential of Bifidobacterium ( B. ) pseudocatenulatum is recognized, its mechanistic interplay with diarrhea-associated inflammatory pathology in calves remains poorly defined. This study investigated how B. pseudocatenulatum alleviates calf diarrhea and intestinal inflammation, with a focus on acetate metabolism and the T helper 17 (Th17)/IL-17A immune axis. Results Diarrheic calves exhibited pronounced gut microbial dysbiosis, metabolic perturbation, and inflammatory activation. Fecal microbiota transplantation (FMT) from healthy calves alleviated diarrhea and was accompanied by enrichment of B. pseudocatenulatum and increased fecal acetate. In vitro, live B. pseudocatenulatum increased acetate production. In complementary murine inflammatory models, B. p seudocatenulatum and acetate alleviated intestinal injury and inflammatory phenotypes. The protective effect was attenuated in the heat-killed B. pseudocatenulatum -treated group. Mechanistically, these protective effects were accompanied by attenuation of pathogen-induced Th17/IL-17A-related responses rather than broad suppression of basal Th17 activation. Pharmacological blockade of free fatty acid receptor 2 (FFAR2) attenuated the protective effect of live B. pseudocatenulatum , supporting the involvement of acetate-associated receptor signaling. Conclusion This study revealed B. pseudocatenulatum as a microbiota-associated candidate linked to calf diarrhea remission and supports acetate-associated attenuation of pathogen-induced Th17/IL-17A-related inflammatory responses as one component of its protective effect. These findings establish a microbiota–metabolite–immune regulatory framework, providing novel therapeutic strategies for alleviating intestinal inflammation and calf diarrhea.

Microbiome
University of British Columbia (CA), Huazhong Agricultural University (CN), The Ohio State University (US), Zhejiang University (CN)
Zero hunger
Openalex Percentile: Top 9%
Animal health and immunology
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.